The company forecasts 2026 sales to grow by a high single-digit percentage SanofiSAN-2.77%decrease; red down pointing triangle said it would execute a 1 billion-euro ($1.20 billion) share buyback program this year, and posted a rise in fourth-quarter sales. The French drugmaker on Thursday reported …